Published in Brain Res on March 27, 1995
RODENT STROKE MODEL GUIDELINES FOR PRECLINICAL STROKE TRIALS (1ST EDITION). J Exp Stroke Transl Med (2009) 1.49
Different strokes for different folks: the rich diversity of animal models of focal cerebral ischemia. J Cereb Blood Flow Metab (2010) 1.42
Long-term behavioral assessment of function in an experimental model for ischemic stroke. J Neurosci Methods (2011) 1.16
[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats. PLoS One (2013) 1.00
Strain-Related Differences in the Immune Response: Relevance to Human Stroke. Transl Stroke Res (2016) 0.89
Method parameters' impact on mortality and variability in rat stroke experiments: a meta-analysis. BMC Neurosci (2013) 0.88
Inadvertent occlusion of the anterior choroidal artery explains infarct variability in the middle cerebral artery thread occlusion stroke model. PLoS One (2013) 0.86
Protective effect of estrogen in endothelin-induced middle cerebral artery occlusion in female rats. Neurosci Lett (2008) 0.82
The Effects of Exercise on Cognitive Recovery after Acquired Brain Injury in Animal Models: A Systematic Review. Neural Plast (2015) 0.76
Neuronal precursor cell proliferation in the hippocampus after transient cerebral ischemia: a comparative study of two rat strains using stereological tools. Exp Transl Stroke Med (2010) 0.76
Room-temperature ultraviolet nanowire nanolasers. Science (2001) 9.79
Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells. J Immunol (1982) 3.24
Structure of erythrocruorin in different ligand states refined at 1.4 A resolution. J Mol Biol (1979) 2.51
Cloning and expression of a receptor for an insecticidal toxin of Bacillus thuringiensis. J Biol Chem (1995) 2.49
Evidence for lysosomal enzyme recognition by human fibroblasts via a phosphorylated carbohydrate moiety. Biochem J (1978) 2.46
Interleukin 1 activity in the synovial fluid of patients with rheumatoid arthritis. Rheumatol Int (1982) 2.24
Forest ecosystem development in post-mining landscapes: a case study of the Lusatian lignite district. Naturwissenschaften (2001) 2.17
CD24, a mucin-type glycoprotein, is a ligand for P-selectin on human tumor cells. Blood (1997) 1.89
Difference between endothelium-dependent relaxation in arterial and in venous coronary bypass grafts. N Engl J Med (1988) 1.79
Cathepsin K--a marker of macrophage differentiation? J Pathol (2001) 1.77
Synthesis of interleukin 1/endogenous pyrogen in the brain of endotoxin-treated mice: a step in fever induction? J Immunol (1984) 1.71
Glioblastoma cells release interleukin 1 and factors inhibiting interleukin 2-mediated effects. J Immunol (1984) 1.68
An alternative hypothesis of cellular transport of lysosomal enzymes in fibroblasts. Effect of inhibitors of lysosomal enzyme endocytosis on intra- and extra-cellular lysosomal enzyme activities. Biochem J (1978) 1.67
Growth rate of 147 mammary carcinomas. Cancer (1980) 1.62
Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib. Eur J Cancer (2009) 1.62
Raf-1 causes growth suppression and alteration of neuroendocrine markers in DMS53 human small-cell lung cancer cells. Am J Respir Cell Mol Biol (1999) 1.58
CD24, a signal-transducing molecule expressed on human B cells, is a major surface antigen on small cell lung carcinomas. Cancer Res (1992) 1.57
Pharmacokinetics of technetium-99m-MAG3 in humans. J Nucl Med (1990) 1.48
Dynamics of drug regimen compliance--its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol (1990) 1.47
Islet amyloid deposition limits the viability of human islet grafts but not porcine islet grafts. Proc Natl Acad Sci U S A (2010) 1.45
A new polymorph of N-phenyl-phthalimide. Acta Crystallogr Sect E Struct Rep Online (2009) 1.43
Seasonality in clinical onset of type 1 diabetes in belgian patients above the age of 10 is restricted to HLA-DQ2/DQ8-negative males, which explains the male to female excess in incidence. Diabetologia (2004) 1.40
Latitudinal population differentiation in two species of Solidago (Asteraceae) introduced into Europe. Am J Bot (1998) 1.40
Sex differences in the antagonism of swim stress-induced analgesia: effects of gonadectomy and estrogen replacement. Pain (1993) 1.38
Concentrations of lysosomal cysteine proteases are decreased in renal cell carcinoma compared with normal kidney. J Cancer Res Clin Oncol (1997) 1.38
1,3-Di(2-[5-3H]tolyl)guanidine: a selective ligand that labels sigma-type receptors for psychotomimetic opiates and antipsychotic drugs. Proc Natl Acad Sci U S A (1986) 1.37
Interaction of 6-cyano-7-nitroquinoxaline-2,3-dione with the N-methyl-D-aspartate receptor-associated glycine binding site. Mol Pharmacol (1989) 1.36
Direct resorption of bone by human breast cancer cells in vitro. Nature (1978) 1.33
Primary structure of the uracil transport protein of Saccharomyces cerevisiae. Eur J Biochem (1988) 1.31
Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem (1990) 1.27
Auditory sustained attention is a marker of unilateral spatial neglect. Neuropsychologia (1997) 1.24
Evaluating the impact of hospitalists. Ann Intern Med (1999) 1.21
Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med (2001) 1.21
Endothelium-dependent responses in carotid and renal arteries of normotensive and hypertensive rats. Hypertension (1988) 1.19
Activated Raf-1 causes growth arrest in human small cell lung cancer cells. J Clin Invest (1998) 1.17
Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther (1994) 1.16
Nonlinear mezlocillin kinetics due to dose-dependent metabolism. Clin Pharmacol Ther (1983) 1.16
Candida and "20th-century disease". CMAJ (1985) 1.15
Automated examination notification of emergency department images in a picture archiving and communication system. J Digit Imaging (2001) 1.14
Monoclonal antibody to the message sequence Tyr-Gly-Gly-Phe of opioid peptides exhibits the specificity requirements of mammalian opioid receptors. Proc Natl Acad Sci U S A (1983) 1.14
Predominance of the amino-terminal octapeptide fragment of dynorphin in rat brain regions. Nature (1982) 1.12
Activity, expression, and transcription rate of the cathepsins B, D, H, and L in cutaneous malignant melanoma. Cancer (2001) 1.11
Citation characteristics of research published in Emergency Medicine versus other scientific journals. Ann Emerg Med (2001) 1.11
Risk factors for adverse drug reactions--epidemiological approaches. Eur J Clin Pharmacol (1990) 1.11
Expression of opioid peptides in tumors. N Engl J Med (1987) 1.09
Immunohistochemical distribution of alpha-neo-endorphin/dynorphin neuronal systems in rat brain: evidence for colocalization. Proc Natl Acad Sci U S A (1982) 1.07
Cathepsin S and an asparagine-specific endoprotease dominate the proteolytic processing of human myelin basic protein in vitro. Eur J Immunol (2001) 1.07
Crystallization, crystal structure analysis and molecular model of the third domain of Japanese quail ovomucoid, a Kazal type inhibitor. J Mol Biol (1981) 1.06
Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends Neurosci (1988) 1.05
Comparison of the effects of stimulators and inhibitors of resorption on the release of lysosomal enzymes and radioactive calcium from fetal bone in organ culture. Endocrinology (1978) 1.04
Noncyclic crown-type polyethers, pyridinophane cryptands, and their alkali metal ion complexes: synthesis, complex stability, and kinetics. J Am Chem Soc (1977) 1.04
Inducible endothelin mRNA expression and peptide secretion in cultured human vascular smooth muscle cells. Biochem Biophys Res Commun (1990) 1.04
Active therapy for chronic low back pain: part 2. Effects on paraspinal muscle cross-sectional area, fiber type size, and distribution. Spine (Phila Pa 1976) (2001) 1.03
Influence of age and duration of symptoms on fibre type distribution and size of the back muscles in chronic low back pain patients. Eur Spine J (2000) 1.03
Design and synthesis of rhodamine 110 derivative and caspase-3 substrate for enzyme and cell-based fluorescent assay. Bioorg Med Chem Lett (2001) 1.03
Crystallographic refinement of Japanese quail ovomucoid, a Kazal-type inhibitor, and model building studies of complexes with serine proteases. J Mol Biol (1982) 1.02
Identification of pro-opiomelanocortin-derived peptides in the human adrenal medulla. Science (1983) 1.02
The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: inhibition of cell cycle progression and induction of cell death. Oncogene (1999) 1.02
Induction of drug metabolizing enzymes by sulfinpyrazone. Eur J Clin Pharmacol (1981) 1.02
Novel peptide neuronal system in rat brain and pituitary. Science (1981) 1.01
Antibodies specific for alpha-N-acetyl-beta-endorphins: radioimmunoassays and detection of acetylated beta-endorphins in pituitary extracts. J Neurochem (1982) 1.00
Risk factors as reflected by an intensive drug monitoring system. Agents Actions Suppl (1990) 1.00
Image reconstructions with the rotating RF coil. J Magn Reson (2009) 1.00
Dosage frequency and drug-compliance behaviour--a comparative study on compliance with a medication to be taken twice or four times daily. Eur J Clin Pharmacol (1991) 1.00
Colocalization of alpha-neo-endorphin and dynorphin immunoreactivity in hypothalamic neurons. Biochem Biophys Res Commun (1981) 1.00
IL-1 beta- and IL-4-induced down-regulation of autotaxin mRNA and PC-1 in fibroblast-like synoviocytes of patients with rheumatoid arthritis (RA). Clin Exp Immunol (2001) 0.99
A qualitative discrepancy between censored data rank tests. Biometrics (1979) 0.98
A method for testing the specificity of influenza A virus-reactive memory cytotoxic T lymphocyte (CTL) clones in limiting dilution cultures. J Immunol Methods (1984) 0.97
Immunoreactive dynorphin-(1-8) and corticotropin- releasing factor in subpopulation of hypothalamic neurons. Science (1983) 0.97
Astrocytes as antigen-presenting cells. Part II: Unlike H-2K-dependent cytotoxic T cells, H-2Ia-restricted T cells are only stimulated in the presence of interferon-gamma. J Neuroimmunol (1986) 0.97
The genetics of pain and pain inhibition. Proc Natl Acad Sci U S A (1996) 0.96
Non-linear elimination processes of theophylline. Eur J Clin Pharmacol (1983) 0.96
Five-year follow-up study of independent clinical and flow cytometric prognostic factors for the survival of patients with non-small cell lung carcinoma. Cancer Res (1988) 0.96
Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics. Lymphology (2000) 0.96
Distribution and activity of calcineurin in rat tissues. Evidence for post-transcriptional regulation of testis-specific calcineurin B. Eur J Biochem (1995) 0.96
Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine. Anesthesiology (1998) 0.95
Dictyosomes participate in the intracellular pathway of storage proteins in developing Vicia faba cotyledons. Eur J Cell Biol (1984) 0.95
Subtype-selective inhibition of N-methyl-D-aspartate receptors by haloperidol. Mol Pharmacol (1996) 0.94
Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res (1998) 0.94
Neuroprotective activity of a new class of steroidal inhibitors of the N-methyl-D-aspartate receptor. Proc Natl Acad Sci U S A (1997) 0.94
Relative contents and concomitant release of prodynorphin/neoendorphin-derived peptides in rat hippocampus. Proc Natl Acad Sci U S A (1983) 0.93
Comparative effects of famotidine and cimetidine on antipyrine kinetics in healthy volunteers. Br J Clin Pharmacol (1984) 0.93
Phorbol ester promotes a sustained down-regulation of endothelin receptors and cellular responses to endothelin in human vascular smooth muscle cells. Biochem Biophys Res Commun (1990) 0.93
Emergency percutaneous coronary dilatation for acute myocardial infarction in Behçet's disease. Eur Heart J (1987) 0.93
Molecular characterisation of kappa-5, a major antigenic glycoprotein from Schistosoma mansoni eggs. Mol Biochem Parasitol (2009) 0.93
[Inhibition of the uptake or alpha-methylnoradrenaline by the heart by sympathomimetic amines]. Naunyn Schmiedebergs Arch Exp Pathol Pharmakol (1965) 0.92
Regional distribution of dynorphin and neo-endorphin peptides in rat brain, spinal cord, and pituitary. J Neurosci (1983) 0.92
The NMDA receptor antagonist MK-801 prevents long-lasting non-associative morphine tolerance in the rat. Brain Res (1992) 0.92
Rat strain and vendor differences in collateral anastomoses. J Cereb Blood Flow Metab (1997) 0.92
Identification, cloning, and characterization of a major cat flea salivary allergen (Cte f 1). Mol Immunol (2000) 0.92
Distribution of gastrin releasing peptide--bombesin-like immunostaining in rat brain. Brain Res (1982) 0.92
The effects of memantine on prepulse inhibition. Neuropsychopharmacology (2009) 0.92
The inhibition of cathepsin S by its propeptide--specificity and mechanism of action. Eur J Biochem (1997) 0.92
Cathepsin K expression in human lung. Adv Exp Med Biol (2000) 0.92
Characterization and cloning of a major high molecular weight house dust mite allergen (Der f 15) for dogs. Vet Immunol Immunopathol (2001) 0.91
Immunohistochemical distribution of dynorphin B in rat brain: relation to dynorphin A and alpha-neo-endorphin systems. Proc Natl Acad Sci U S A (1983) 0.91
Intercellular adhesion molecule-1 gene expression by glial cells. Differential mechanisms of inhibition by IL-10 and IL-6. J Immunol (1995) 0.91
Non-oral etiologies of oral malodor and altered chemosensation. J Periodontol (1992) 0.90
Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4. J Neuroendocrinol (2012) 0.90
A dynorphinergic pathway of Leu-enkephalin production in rat substantia nigra. Nature (1984) 0.90